The Institute of Cancer Research (ICR)


London, United Kingdom

Publications in cooperation with FAU scientists

Go to first page Go to previous page 1 of 3 Go to next page Go to last page
Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E.-M.,... Robson, M.E. (2019). A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical Cancer Research, 25(9), 2717-2724.
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3).
Carreno, G., Boult, J.K.R., Apps, J., Gonzalez-Meljem, J.M., Haston, S., Guiho, R.,... Martinez-Barbera, J.P. (2019). SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocrine-Related Cancer, 26(3), 355-366.
Capper, D., Jones, D.T.W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D.,... Pfister, S.M. (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), 469-474.
Painter, J.N., O'Mara, T.A., Morris, A.P., Cheng, T.H.T., Gorman, M., Martin, L.,... Spurdle, A.B. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine, 7(5), 1978-1987.
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1).
Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F.,... Gronchi, A. (2017). An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology, 28(10), 2399-2408.
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651.
Guo, Q., Burgess, S., Turman, C., Bolla, M.K., Wang, Q., Lush, M.,... Pharoah, P.D.P. (2017). Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46(6), 1814-1822.
Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799.
Dietrich, C.F., Bamber, J., Berzigotti, A., Bota, S., Cantisani, V., Castera, L.,... Thiele, M. (2017). EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in der Medizin, 38(4), 377-394.
Barrdahl, M., Rudolph, A., Hopper, J.L., Southey, M.C., Broeks, A., Fasching, P.,... Chang-Claude, J. (2017). Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. International Journal of Cancer, 141(9), 1830-1840.
Muranen, T.A., Greco, D., Blomqvist, C., Aittomaki, K., Khan, S., Hogervorst, F.,... Nevanlinna, H. (2017). Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine, 19(5), 599-603.
Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T.,... Lindblom, A. (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8(61), 102769-102782.
Boult, J.K., Apps, J.R., Hölsken, A., Hutchinson, J.C., Carreno, G., Danielson, L.S.,... Robinson, S.P. (2017). Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma. Brain Pathology.
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q.,... Neven, P. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research, 19(1).
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876.
Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A.,... Simard, J. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, 7(49), 80140-80163.
Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B.,... Zheng, W. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control, 27(5), 679-93.
Thompson, D.J., O'Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Folkerd, E.,... Spurdle, A.B. (2016). CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocrine-Related Cancer, 23(2), 77-91.

Last updated on 2017-24-01 at 08:41